Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X
The search was filtered to include only randomized controlled trials (RCTs) or meta-analyses of human data
Key metabolic pathways affected Semaglutide does more than control blood sugar levels
It might still be getting signals to be like how he was on a GLP-1. A spokesperson for semaglutide manufacturer Novo Nordisk noted that there are numerous studies exploring the association between using the drugs and reductions in behaviors sometimes linked to addiction
They have also been shown to reduce the rates of major adverse cardiovascular events, comprising non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, in patients with type 2 diabetes mellitus
The World Health Organization International Clinical Trials Registry Platform (ICTRP) and the ClinicalTrials.gov registry were also reviewed to find unpublished or ongoing trials